Dottorato in Fisiopatologia Medica

Contatti

Attività di ricerca

PROJECT

“Artificial intelligence and machine learning applications in Nuclear Medicine for the identification of predictive and prognostic factors in oncological and endocrinological diseases”

 

ATTENDED PhD COURSES & OTHER TRAINING

A.A. 2023/2024

Medical Physiopathology PhD Classes

• Alteration of intestinal microbioma as organ insufficiency: practical implications – Prof. Francesco Giuseppe De Rosa (1 Jun 2024, 2h)
• Biology and Diagnosis of SARS CoV2 – Prof. Cristina Costa (6 Jun 2024, 2h)
• Cardiac electric physiopathological properties – Prof. Gaetano De Ferrari (8 Jun 2024, 2h)
• Therapeutic strategies for liver transplant – Prof. Renato Romagnoli (8 Jun 2024, 2h)

 

Other courses

• Brain PET imaging and SPM analysis – Prof. Morbelli (Oct 2024, 6h)
• Advanced training in clinical oncology - Gustave Roussy Institute (Sept-Oct 2024, 20h)
• Swetaly Mentoring Programme classes (Jan-Sept 2024, 10h)

 

Attended Scientific Events

• 37^th Annual Congress of the European Association of Nuclear Medicine (EANM)

Hamburg, 19 - 23 Oct 2024

• Annual Congress of the American Society of Nuclear Cardiology (ASNC)

Online, 5-7 Sept 2024

• XVI Congress of the Italian Association of Nuclear Medicine (AIMN)

Milan, 20 - 23 Jun 2024

 

Research Experience Abroad

• Nuclear Medicine Internship and Research training

Institute Gustave Roussy, Villejuif, France

 

A.A. 2022/2023

PhD Classes

June 13, 2023 - Cancer survivors: pathophysiology of late-effects and challenges in their management - Prof.ssa Arvat

June 29, 2023 - Diabetic nephropathy – Prof.ssa Gruden

September 5, 2023 - Extracellular vesicles and liquid biopsy - Prof.ssa Bussolati 

September 7, 2023 - Impact of the metabolic syndrome on the digestive tract - Prof.ssa Bugianesi

 

UniTo Statistics Course

March 6-9-10, 2023 - Statistica di base

March 7-8, 2023 - Inferenza causale in epidemiologia clinica

March 15-16, 2023 - Disegno dello studio e misure epidemiologiche

March 23, 2023 - La dimensione campionaria

April 13-14, 2023 - Ricerca in campo diagnostico

 

E-learning courses

• La radioprotezione ai sensi del D.Lgs. 101/2020 per medici e odontoiatri (4 Dec 2022, 8h)

FNOMCeO FAD course (ECM 353910, provider code 2603) - 8 ECM credits

• Sicurezza e interventi di emergenza negli ambienti di lavoro (24 Dec 2022, 12h)

FNOMCeO FAD course (ECM 351069, provider code 2603) - 12 ECM credits

• Finding Funding Opportunities (19 Oct 2023, 3.5 h)

Nature Masterclasses Online Course

 

Research Experience Abroad

• 05/05/2023 - 20/05/2023 Nuclear Medicine Internship and Research training

Institute Gustave Roussy, Villejuif, France

 

Attended Scientific Events

• “Introduction to Radiomics for Nuclear Medicine”

Online webinar AIMN, 16 Jan 2023, 2h

• “AIRC calls for Individual Grant 2023”

Online webinar AIRC, 08 Feb 2023, 1.5 h

• “Online Guidance for PhD Candidates”

Online webinar UniTo, 21 Feb 2023, 2h

• “Opportunità per le imprese – Dottorati e Industria”

Grugliasco, 22 Feb 2023, 2.5h

• “L’impatto della ricerca sul mercato del lavoro”

Online webinar UniTo, 23 Feb 2023, 1h

• “Progetti Terza Missione per la disseminazione e la divulgazione della ricerca”

UniTo, 2 Mar 2023, 1h

• “UNITA Days – European UNITA Alliance”

Torino – Campus Luigi Einaudi, 13 Mar 2023, 1.5h

• “How to value artificial intelligence in Nuclear Medicine”

Online webinar EANM/ESMIT, 24 Mar 2023, 1h

• “New York Career Day 2023: Opportunities for Italian Researchers”

Online Webinar AIRIcerca, 29 Mar 2023, 2.5h

• “Dosimetry across the water”

Online webinar EANM/ESMIT, 14 Apr 2023, 1.5h

• “XXVII corso nazionale di aggiornamento in medicina nucleare e imaging molecolare”

Catania, 12-15 May 2023

• “My 3-minute PhD thesis" - European UNITA alliance

Turin, 28 Jun 2023

• “36^th Annual Congress of the European Association of Nuclear Medicine”

Vienna, 9 - 13 Sept 2023

• AIMN Course - “Metodologia della Ricerca e Pubblicazione Scientifica”

Milan, 20 Oct 2023

 

A.A. 2021/2022

Approaches to scientific research (22 hours)

June 28, 2022 - Precision medicine in oncology: putting drivers and targets in context – Prof. Livio Trusolino

June 30, 2022 - How to write a scientific paper – Prof.ssa Riccarda Granata

July 07, 2022 - How to set up an in vivo experimental model – Prof.ssa Stefania Bruno

July 12, 2022 - Fitting regression models: interpretation of regression coefficients, uncertainty measures and hypothesis testing - Prof.ssa Milena Maule

July 19, 2022 - Regression models: from the linear model to the generalised linear models. Interpretation of interactions between predictors - Prof.ssa Milena Maule

September 27, 2022 - Scientific presentations – Prof.ssa Benedetta Bussolati

Pathophysiological basis of diseases (20 hours)

July 05, 2022 - Update on physiology of hypertension – Prof. Franco Veglio

June 21, 2022 - Etiopathogenesis of diabetic retinopathy – Prof. Massimo Porta

September 6, 2022 - Physiopathology of diabetic nephropathy – Prof.ssa Gabriella Gruden

September 8, 2022 - Targets for functional imaging in medicine – Prof.ssa Désirée Deandreis

September 15, 2022 - Physiopathology of autoimmune hepatitis – Prof.ssa Marilena Durazzo *Rescheduled

E-learning courses

05-06/10/2022 – Nature Masterclasses: Managing Research Data (5h) - Link: https://masterclasses.nature.com/managing-research-data/18320206

01/06/2022 – 23/09/2022 Bibliography and bibliometrics like pros. Stay up to date and Develop Literature Syntheses in the Biomedical Domain (14h) - Link: https://elearning.unito.it/strutture_universitarie/course/view.php?id=1321

16/03/2022 – MEDCap Policy Course & Medcap Policy Awareness Certificate (MPAC) UniTo - Link: https://elearning.unito.it/mooc/course/index.php?categoryid=7

03/2022 - Corso di formazione in materia di Igiene e Sicurezza - Rischio Alto in area sanitaria - Settore Ateco 2007 Q 86 - (D. Lgs. 81/08 s.m.i.) (12h)

 

SCIENTIFIC PUBLICATIONS

 A.A. 2023/2024

• Rovera G, Grimaldi S, Dall'Armellina S, Zotta M, Finessi M, Passera R, Deandreis D. Comparison of Digital versus Analog 68Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment. Diagnostics (Basel). 2023 Nov 26;13(23):3535. doi: 10.3390/diagnostics13233535. PMID: 38066776; PMCID: PMC10706683.

 

• Bauckneht M, Lanfranchi F, Rovera G, Morbelli S, Sambuceti G, Belgioia L. Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study). J Nucl Med. 2024 Jun 27:jnumed.124.267586. doi: 10.2967/jnumed.124.267586. PMID: 38906557.

 

• Rovera G, Urso L, Stracuzzi F, Laudicella R, Frantellizzi V, Cottignoli C, Gazzilli M, Guglielmo P, Panareo S, Evangelista L, Filice A, Burroni L, “Accreditamento e Management - HTA” AIMN Working Group. Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting. Clin Transl Imaging. 2024. https://doi.org/10.1007/s40336-024-00653-0

 

• Rovera G, Urso L, Stracuzzi F, Laudicella R, Frantellizzi V, Cottignoli C, Gazzilli M, Guglielmo P, Panareo S, Evangelista L, Filice A, Burroni L, “Accreditamento e Management - HTA” AIMN Working Group. Advantages of SiPM-based Digital PET/CT Technology in Nuclear Medicine Clinical Practice: a Systematic Review – Part 2. Clin Transl Imaging. 2024. https://doi.org/10.1007/s40336-024-00650-3

 

• Dondi F, Miceli A, Rovera G, Feudo V, Battisti C, Rondini M, Marongiu A, Mura A, Camedda R, De Feo MS, Conte M, Gorica J, Ferrari C, Nappi AG, Santo G. Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? Bioengineering (Basel). 2024 Jul 14;11(7):714. doi: 10.3390/bioengineering11070714.

 

• Rovera G, Grimaldi S, Oderda M, Marra G, Calleris G, Iorio GC, Falco M, Grossi C, Passera R, Campidonico G, Mangia ML, Deandreis D, Faletti R, Ricardi U, Gontero P, Morbelli S. Comparative Performance of 68Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy. Diagnostics (Basel). 2024 Sep 5;14(17):1964. doi: 10.3390/diagnostics14171964.

 

• Raffa S, Sofia L, Girtler N, Pardini M, Arnaldi D, Orso B, Donegani MI, D'Amico F, Lanfranchi F, Rovera G, Massa F, Mattioli P, Sambuceti G, Bauckneht M, Morbelli S. Metabolic and dopaminergic correlates of intellectual enrichment in de-novo Parkinson's disease patients. Q J Nucl Med Mol Imaging. 2024 Sep;68(3):187-193. doi: 10.23736/S1824-4785.24.03585-4.

 

• Garelli G, Rovera G, Levis M, Lesca A, Pellerino A, Bruno F, Agosti A, Mangia ML, Cioffi M, Coccarelli A, Morana G, Ricardi U, Rudà R, Morbelli S, Zotta M. [18F]DOPA PET for lesion definition and contouring using different thresholds in patients with gliomas. Q J Nucl Med Mol Imaging. 2024 Sep;68(3):200-206. doi: 10.23736/S1824-4785.24.03587-8.

 

• Dall’Olio FG, Zrafi W, Roelants V, Ambrosini V, Rovera G, Novello S, Deandreis D, Garcia C, Besse B et al. Metabolic tumor volume assessed by 18F FDG - PET CT scan as a predictive biomarker for immune checkpoint blockers in advanced NSCLC and its biological correlates. Clin Cancer Res. 2024 Oct 22. doi: 10.1158/1078-0432.CCR-24-1993.

 

Accepted and awaiting publication

• Finessi M, Cioffi M, Grimaldi S, Fronda M, Rovera G, Passera R, Fonio P, Morbelli S, Doriguzzi Breatta A. ALBI score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT). La Radiologia Medica. 2024.

 

Completed and under submission

• Daverio AL , Coccarelli A, Henry T, Kamoun T , Rovera G , Danu A, Morbelli SD, Deandreis D. PET imaging for therapy assessment in symptomatic myeloma, including Minimal Residual Disease.

 

A.A. 2022/2023

• Alongi P, Rovera G, Stracuzzi F, Popescu CE, Minutoli F, Arnone G, Baldari S, Deandreis D, Caobelli F. Artificial Intelligence in Breast Cancer: A Systematic Review on PET Imaging Clinical Applications. Curr Med Imaging. 2023;19(8):832-843. doi: 10.2174/1573405619666230126093806. PMID: 36703586.

 

• Oderda M, Grimaldi S, Rovera G, Delsedime L, D'Agate D, Lavagno F, Marquis A, Marra G, Molinaro L, Deandreis D, Gontero P. Robot-assisted PSMA-radioguided Surgery to Assess Surgical Margins and Nodal Metastases in Prostate Cancer Patients: Report on Three Cases Using an Intraoperative PET-CT Specimen Imager. Urology. 2023 Sep 3:S0090-4295(23)00730-6. doi: 10.1016/j.urology.2023.08.013. Epub ahead of print. PMID: 37669707.

 

• Chierichetti F, Burroni L, Guglielmo P, Rovera G, Filice A. Raccomandazione per la definizione degli standard da adottare per la qualità delle immagini nel manuale di qualità, come previsto dal Dlgs 101/2020. Vrs. 01/2023.

 

• Rovera G, de Koster EJ, Rufini V, Zollino M, Zagaria L, Giammarile F, Vidal-Sicart S, Valdés Olmos R, Collarino A. ^99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a European expert panel. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3375-3389. doi: 10.1007/s00259-023-06290-5. Epub 2023 Jun 13. PMID: 37310426.

 

• Rovera G, Fariselli P, Deandreis D. Artificial Intelligence and Machine Learning in Nuclear Medicine. In: Endoradiotherapy. 1st ed. Springer; 2023 Nov.

 

• Rovera G, Grimaldi S, Oderda M, Finessi M, Giannini V, Passera R, Gontero P, Deandreis D. Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative ⁶⁸Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study. Diagnostics (Basel). 2023 Sep 21;13(18):3013. doi: 10.3390/diagnostics13183013. PMID: 37761380; PMCID: PMC10529304.

 

Completed under submission

• Guido Rovera, Luca Urso, Federica Stracuzzi, Riccardo Laudicella, Viviana Frantellizzi, Chiara Cottignoli, Maria Gazzilli, Priscilla Guglielmo, Stefano Panareo, Laura Evangelista, Angelina Filice, Luca Burroni, “Accreditamento e Management - HTA” AIMN Working Group. Advantages of the SiPM-based Digital PET/CT Technology in Nuclear Medicine Clinical Practice: a Systematic Review – Part 1 & Part 2

 

Submitted under evaluation

• Dall’Olio FG, Zrafi W, Roelants V, Ambrosini V, Rovera G, Novello S, Deandreis D, Garcia C, Besse B et al. Metabolic tumor burden assessed by ¹⁸F-FDG PET scan as a predictive biomarker for immune checkpoint blockers in advanced NSCLC and its biological correlates: a multicentric study.

 

• Rovera G, Grimaldi S, Dall’Armellina S, Zotta M, Finessi M, Passera R, Deandreis D. Comparison of digital versus analog ⁶⁸Ga-PSMA-11 PET/CT performance in hormone-sensitive prostate cancer patients with early biochemical recurrence or persistence after radical treatment.

 

A.A. 2021/2022

• Ceci F, Rovera G, Iorio GC, Guarneri A, Chiofalo V, Passera R, Oderda M, Dall'Armellina S, Liberini V, Grimaldi S, Bellò M, Gontero P, Ricardi U, Deandreis D. Event-free survival after 68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy. Eur J Nucl Med Mol Imaging. 2022 Feb 26. doi: 10.1007/s00259-022-05741-9.

 

• Rovera G, Grimaldi S, Dall’Armellina S, Passera R, Oderda M, Iorio GC, Guarneri A, Gontero P, Ricardi U, Deandreis D. Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence. Diagnostics. 2022; 12(6):1309. https://doi.org/10.3390/diagnostics12061309

 

• Rovera G, Fariselli P, Deandreis D. Development of a REDCap-based workflow for high-volume relational data analysis on real-time data in a medical department using open source software. Comput Methods Programs Biomed. 2022 Sep 6;226:107111. doi: 10.1016/j.cmpb.2022.107111. PMID: 36108572.

 

• Rovera G, Polverari G, Ceci F. PSMA based PET imaging for initial diagnosis and staging of prostate cancer. In Evangelista L., Ceci F. Nuclear medicine in prostate cancer management. 1st ed. Torino: Minerva Medica Edizioni; 2022. ISBN: ISBN: 9788855321167

 

• Califaretti E & Dall'armellina S, Rovera G, Finessi M, Deandreis D. The role of PET/CT in thyroid autoimmune diseases. Q J Nucl Med Mol Imaging. 2022 May 25. doi: 10.23736/S1824-4785.22.03464-1. Epub ahead of print. PMID: 35612371.

 

PRESENTATION OF PAPERS, POSTERS, GIVEN SPEECHES AT CONFERENCES

A.A. 2023/2024 

• 23/10/2024 Conference speech: "Radioguided robotic surgery and artificial intelligence / machine learning applications in Nuclear Medicine"

“Research for Future”, 23/10/2024, Turin, Italy

• 23/10/2024 Oral presentation (author): "Interplay Between Radiomics Features of pre- and post-procedural SPECT and PET Imaging for the Prediction of Response to Selective Internal Radiation Therapy (SIRT) for Hepatocellular Carcinoma (HCC): Preliminary Analysis"

“EANM Congress 2024”, 19-23/10/2024, Hamburg, Italy

• 21/10/2024 Oral presentation (author): "Semiquantitative Approach to DaT SPECT in Scans Without Evidence of Dopaminergic Deficit (SWEDD) in the Era of the Biological Staging of Alpha-synucleinopathies: a PPMI Analysis"

“EANM Congress 2024”, 19-23/10/2024, Hamburg, Italy

• 21/10/2024 Oral presentation (co-author): "Imaging shapes the long-term oncological outcome of oligorecurrent prostate cancer patients submitted to metastasis-directed therapy (the PRECISE-MDT study)"

“EANM Congress 2024”, 19-23/10/2024, Hamburg, Germany

• 20/10/2024 Oral presentation (co-author): "Metabolic correlates of epileptogenic activity in patients with autoimmune encephalitis (AE): visual and voxel-based approach to brain FDG PET"

“EANM Congress 2024”, 19-23/10/2024, Hamburg, Germany

• 20/10/2024 e-Poster presentation (co-author): "Disease-tailored parameters and cut-offs for the diagnosis of Progressive Supranuclear Palsy (PSP): a semiquantitative approach to Dopamine Transporter (DaT) imaging in the memory clinic setting"

“EANM Congress 2024”, 19-23/10/2024, Hamburg, Germany

• 20/10/2024 e-Poster presentation (co-author): "The need of age-adjusted cut-offs for Z-score of DaT SPECT striatal binding ratio (SBR) to support the differential diagnosis between Parkinson’s Disease (PD) and Essential Tremor (ET)"

“EANM Congress 2024”, 19-23/10/2024, Hamburg, Germany

• 21/06/2024 Conference speech: "Machine Learning Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative ⁶⁸Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 Oral presentation (co-author): "A case-control approach to the interplay between different chimeric antigen receptor (CAR) T-cell products and metabolic tumor volume (MTV) in lymphomas"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 Oral presentation (co-author): "The prognostic role of [¹⁸F]FDG PET/CT for suspected recurrence or monitoring systemic treatment in triple-negative breast cancer: preliminary results of TRINE-PET trial"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 Oral presentation (co-author): “Looking for a biological meaning of DAT SPECT imaging in patients with scans without evidence of dopaminergic deficit (SWEDD): analysis of the PPMI data"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (author): "Advantages of SIPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review by the AIMN HTA Working Group"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (author): "Interplay between radiomics features of pre- and post-procedural SPECT and PET imaging for the prediction of response to selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC): preliminary analysis"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (author): "Comparative performance of ⁶⁸Ga-PSMA-11 PET/CT and conventional imaging in staging high-risk prostate cancer patients candidate to radical prostatectomy"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (co-author): "Dose optimization in adult pet imaging: a balance between patient safety and maximum image quality. Review of the literature and future perspectives"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (co-author): "The need of age-adjusted cut-offs for Z-score of DAT SPECT striatal binding ratio (SBR) to support the differential diagnosis between Parkinsons disease (PD) and essential tremor (ET)"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (co-author): "ALBI score affects overall survival (OS) in patients with hepatocellular carcinoma patients (HCC) treated with selective internal radiation therapy (SIRT)"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (co-author): "Comparison of target definition based on [18F]DOPA PET using different thresholds in patients with gliomas: implications for radiotherapy (RT) and surgical planning"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (co-author): "The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of TRINE-PET trial"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (co-author): "Superior efficacy of PSMA PET/CT over choline PET/CT in directing metastasis-directed therapy in oligorecurrent prostate cancer: insights from a propensity score-matched analysis in a multicentric real-world cohort (the PRECISE-MDT study)"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (co-author): "Comparative effectiveness of PSMA radiopharmaceuticals in oligorecurrent prostate cancer metastases directed therapy: a secondary analysis from the multicentric precise-MDT study"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (co-author): "Maximum tumor dissemination (D_max) provides prognostic insights on the transition from oligometastatic to polymetastatic disease in prostate cancer patients (PCA)"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 20/06/2024 e-Poster (co-author): "Head-to-head comparison of PSMA PET/CT and MPMRI with histopathology as gold standard for the determination of local extension of prostate cancer"

“AIMN Congress 2024”, 20-23/06/2024, Milan, Italy

• 26/01/2024 Conference speech: "Tecnologie digitali costo-efficaci a supporto della ricerca scientifica e della pratica clinica"

“Evoluzione Tecnologica, Digital Health & Nuclear Medicine” - AIMN Gds HTA webinar, 26/01/2024, Italy

 

A.A. 2022/2023

• 11/09/2023 Poster (author): “Intraoperative PET/CT specimen imaging for the evaluation of surgical margins and nodal metastases in prostate cancer patients undergoing robot-assisted PSMA-radioguided surgery”

European Association of Nuclear Medicine (EANM) Congress, Vienna, 9-13 Sept 2023

 

• 10/09/2023 Poster (author): “Comparison of digital versus analog 68Ga-PSMA-11 PET/CT performance in hormone-sensitive prostate cancer patients with early biochemical recurrence or persistence”

European Association of Nuclear Medicine (EANM) Congress, Vienna, 9-13 Sept 2023

 

• 10/09/2023 Poster (author): “Multimodality approach with 68Ga-PSMA-11 PET/CT in staging high-risk prostate cancer patients candidate to radical prostatectomy”

European Association of Nuclear Medicine (EANM) Congress, Vienna, 9-13 Sept 2023

 

• 25/10/2022 Conference speech: "Neoplasie del cavo orale: la Medicina Nucleare"

“Corso teorico-pratico su patologie neuroradiologiche e sulle neoplasie del capocollo”, 24-25/10/2022, Turin, Italy

 

A.A. 2021/2022

• 18/10/2022 e-Poster presentation (author): "Prediction of M1b stage in prostate cancer patients undergoing ⁶⁸Ga-PSMA-11 PET/CT for early biochemical recurrence or persistence"

“EANM Congress 2022”, 15-19/10/2022, Barcellona, Spain

 

• 15/10/2022 Highlights and Oral presentation (co-author): "Computational Models for Patient Stratification in Molecular Radiotherapy (COMPASS): a first dataset analysis in hyperthyroid patients"

“EANM Congress 2022”, 15-19/10/2022, Barcellona, Spain

 

• 16/09/2022 Conference speech: "Nuclear Medicine molecular imaging for prostate cancer staging"

“Multidisciplinary Prostate Cancer Update Meeting”, 16/09/2022, Turin, Italy

 

• 24/06/2022 Conference speech: "Il nodulo tiroideo captante alla ¹⁸F-FDG PET/CT: cosa significa e cosa fare?"

“I venerdì della tiroide”, 24/06/2022, Online webinar, Italy

 

• 11/06/2022 e-Poster presentation (author): “Predictors of distant metastases at ⁶⁸Ga-PSMA-11 PET/CT in early-recurrent hormone-sensitive prostate cancer (HSPC) patients”

SNMMI Annual Meeting, 11-14/06/2022, Vancouver, Canada

 

• 13/05/2022 Oral presentation (author): “Predictors of bone metastases at ⁶⁸Ga-PSMA-11 PET/CT in hormone-sensitive prostate cancer (HSPC) patients with early biochemical recurrence or persistence”

XV Congresso Nazionale AIMN, 12-15/05/2022, Rimini, Italy

 

PARTICIPATION TO NATIONAL & INTERNATIONAL RESEARCH PROJECTS

A.A. 2023/2024

• Multicenter Study – Italian Association of Nuclear Medicine (AIMN)

Project: 18F-FDG PET/CT in triple negative breast cancer: a multicenter real world

experience from the Italian Association of Nuclear Medicine (AIMN)

Role: Co-participant

 

• Review – Gustave Roussy Institute

Project: PET imaging for therapy assessment in symptomatic myeloma, including Minimal Residual Disease

Role: Co-participant

 

• Review – Italian Association of Nuclear Medicine (AIMN)

Project: Advantages of SiPM-based Digital PET/CT Technology in Nuclear Medicine Clinical Practice: a Systematic Review

Role: Coordinator & First author

 

• Multicenter Study – University of Freiburg

Project: [18F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/CT for the detection of bone barrow involvement in children and adolescents with rhabdomyosarcoma Role: Co-participant

 

A.A. 2022/2023

• Horizon Europe Framework Programme (2023)

Project: Dynamic multiorgan and multiscale virtual twins for molecular radiotherapy

Role: Co-participant

 

• Multicenter Study – Italian Association of Nuclear Medicine (AIMN) (2023)

Project: 18F-FDG PET/CT in triple negative breast cancer: a multicenter real world experience from the Italian Association of Nuclear Medicine (AIMN)

Role: Co-participant

 

TEACHING ACTIVITIES AND STUDENTS’ MENTORSHIP

Institution: University of Turin, Turin, Italy

A.A. 2023/2024

TEACHING ACTIVITIES

• Corso di Laurea in Infermieristica – Can. A/B/C (A.A. 2023/2024)

Course: Funzionamento del corpo umano - Diagnostica per immagini

Dates: 20/12/2023, 21/12/2023, 22/12/2023, 15/01/2024

Duration: 12 hours

Topics: Basics of Nuclear Medicine molecular imaging, ¹⁸F-FDG PET/CT applications (oncology, neurology, infection/inflammation)

• Corso di Laurea in Infermieristica – Can. A/B/C (A.A. 2023/2024)

Course: Funzionamento del corpo umano - Diagnostica per immagini

Activity: Written / Oral Examination (Nuclear Medicine)

Dates: 25/01/2024, 02/02/2024, 20/02/2024, 01/07/2024, 15/07/2024

• Corso di Laurea in Tecniche di Radiologia Medica, per Immagini e Radioterapia (A.A. 2023/2024)

Course: Medicina Nucleare

Dates: 25/01/2024

Duration: 2 hours

Topics: Theranostics, Nuclear Medicine applications in prostate cancer

• Master Program in Molecular Biotechnology (A.A. 2023/2024)

Course: In vivo diagnostics: PET/SPECT/CT

Dates: 25/03/2024, 15/04/2024, 27/05/2024, 03/06/2024

Duration: 8 hours

Topics: PET/CT applications in prostate cancer, Renal scintigraphy,                          Radiomics / AI & ML, Myocardial SPECT/PET, Transarterial radioembolization

• Corso di Laurea Magistrale in Medicina e Chirurgia – Can. A/B/C/D (A.A. 2023/2024)

Course: Diagnostica per immagini e Medicina Nucleare

Activity: Oral Examination (Nuclear Medicine)

Dates: 06/02/2024, 27/02/2024, 09/04/2024, 02/07/2024, 03/07/2024, 09/07/2024, 23/07/2024, 30/07/2024, 02/09/2024, 03/09/2024, 06/09/2024, 23/09/2024, 24/09/2024

• Corso di Laurea Magistrale in Medicina e Chirurgia – Can. A/B/C/D (A.A. 2023/2024)

Course: Diagnostica per immagini e medicina nucleare

Date: 27/05/2024, 28/05/2024, 29/05/2024, 30/05/2024, 17/06/2024, 18/06/2024, 19/06/2024

Duration: 12 hours

Topics: Scintigraphic, SPECT/CT and PET/CT applications in nuclear medicine

 

STUDENTS’ MENTORSHIP

• Medicine and Surgery - Graduation Thesis Project Mentorship

Project title: “Impact of low-carbohydrate, high-fat diet on regional glucose brain metabolism in patients undergoing [18F]FDG PET scanning for inflammation/infection”

 

A.A. 2022/2023

Teaching activities

• Corso di Laurea in Infermieristica – Can. A/B/C (A.A. 2022/2023)

Course: Funzionamento del corpo umano - Diagnostica per immagini         Duration: 6 hours       Topics: ¹⁸F-FDG PET/CT

 

• Corso di Laurea in Infermieristica – Can. A/B/C (A.A. 2022/2023)

Course: Funzionamento del corpo umano - Diagnostica per immagini         Written / Oral Examination (Nuclear Medicine)       Duration: 5 sessions

 

• Corso di Laurea in Tecniche di Radiologia Medica, per Immagini e Radioterapia (A.A. 2022/2023)

Course: Medicina Nucleare II, Modulo Ricerca 4 - Medicina Nucleare         Duration: 12 hours       Topics: Nuclear Medicine clinical applications

 

• Corso di Laurea Magistrale in Medicina e Chirurgia – Can. A/B (A.A. 2022/2023)

Course: Diagnostica per immagini e Medicina Nucleare         Duration: 16 hours       Topics: Scintigraphic and PET/CT applications in nuclear medicine

 

• Corso di Laurea Magistrale in Medicina e Chirurgia – Can. A/B (A.A. 2022/2023)

Course: Diagnostica per immagini e Medicina Nucleare         Oral Examination (Nuclear Medicine)       Duration: 12 sessions

 

Undergraduate Students’ training and mentorship

• Medicine and Surgery - Graduation Thesis Project Mentorship

Project title: “Multimodality approach with 68Ga-PSMA-11 PET/TC, in high-risk prostate cancer patients candidate to radical prostatectomy”

 

• Nuclear Medicine – Specialization Thesis Project Mentorship

Project title: “Innovative use of 68 Ga-PSMA-11 in high risk prostate cancer patients: from staging to radioguided sugery”

 

Interdepartimental Projects Collaborations

• Project Title: “Predictive value of 18F-FDG PET/CT in treatment response assessment of patients with radioiodine-refractory thyroid cancer treated with Lenvatinib”

Department: Endocrinology, University of Turin

• Project Title: “Predictive value of baseline 18F-FDG PET/CT whole-body volumetric parameters in treatment response assessment of patients with radioiodine-refractory thyroid cancer treated with Lenvatinib”

Department: Endocrinology, University of Turin

• Project Title: “PSMA-guided management of recurrent post-prostatectomy patients”

Department: Radiotherapy, University of Turin

• Project Title: “PSMA-guided management of prostate cancer patients relapsing after prostatectomy and prostate-bed RT”

Department: Radiotherapy, University of Turin

 

A.A. 2021/2022

Teaching activities

• Corso di Laurea in Tecniche di Radiologia Medica, per Immagini e Radioterapia (A.A. 2021/2022)

Course: Medicina Nucleare         Duration: 2 hours       Topics: Renal scintigraphy

 

• Master Program in Molecular Biotechnology (A.A. 2021/2022)

Course: In vivo diagnostics: PET/SPECT/CT        Duration: 4 hours

Topics: 18F-FDG PET/CT in oncology, PET/CT applications in prostate cancer

 

• MedInTo Medicine and Surgery (Corso di Laurea Magistrale in Medicina e Chirurgia in lingua inglese) (A.A. 2021/2022)

Course: Medical Radiology     Duration: 2 hours     Topics: Basic concepts of Nuclear Medicine

 

• Corso di Laurea Magistrale in Medicina e Chirurgia (A.A. 2021/2022)

Course: Diagnostica per immagini e medicina nucleare            Duration: 2 hours

Topics: ¹⁸F-FDG PET/CT applications in oncology

 

• Corso di Laurea Magistrale in Medicina e Chirurgia (A.A. 2021/2022)

Course: ADE - Inquadramento diagnostico e indirizzi terapeutici delle principali patologie neoplastiche

Duration: 2 hours            Topics: PET/CT applications in prostate cancer and lung cancer

 

Undergraduate Students’ training and mentorship

• Medicine and Surgery - Undergraduate students’ internship training (A.A. 2021/2022)

Topic: PET/CT applications in Nuclear Medicine             Duration: 5 hours

 

• Medicine and Surgery - Graduation Thesis Project Mentorship

Project title: “Multimodality approach with ⁶⁸Ga-PSMA-11 PET/TC, in high-risk prostate cancer patients candidate to radical prostatectomy”

 

ACTIVE PARTICIPATION TO SCIENTIFIC ASSOCIATIONS ACTIVITIES

Active member of the Scientific Committee of the “Management and Health Technology Assessment (HTA)” study group of the Italian Association of Nuclear Medicine (AIMN)